Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia.
| Image |  |
|---|---|
| Description | scientific article published on 8 June 2015 |
| Author/s |
author: Guillaume Paré |
| Publication date | July 3, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |